Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Total Non-Current Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Total Non-Current Liabilities ₹43 Cr₹38 Cr₹45 Cr₹38 Cr₹36 Cr

What is the latest Total Non-Current Liabilities ratio of BAL PHARMA ?

The latest Total Non-Current Liabilities ratio of BAL PHARMA is ₹43 Cr based on Mar2026 Consolidated results.
Year Total Non-Current Liabilities
Mar2026₹43 Cr
Mar2025₹38 Cr
Mar2024₹45 Cr
Mar2023₹38 Cr
Mar2022₹36 Cr

How is Total Non-Current Liabilities of BAL PHARMA Trending?

Years Total Non-Current Liabilities % Change
Mar2026 ₹43 Cr
12.71
Mar2025 ₹38 Cr
-14.36
Mar2024 ₹45 Cr
18.02
Mar2023 ₹38 Cr
4.32
Mar2022 ₹36 Cr -

Compare Total Non-Current Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹145.5 Cr -7.6% -10.3% 16.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,684.0 Cr -1.4% -6.5% 5.5% Stock Analytics
DIVIS LABORATORIES ₹241,311.0 Cr -2% -2.7% 40.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹173,079.0 Cr -1.8% -7% 29.6% Stock Analytics
CIPLA ₹107,528.0 Cr 0.1% -3% -15.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,667.0 Cr 0.2% 6% -2.4% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-7.6%

-10.3%

16.1%

SENSEX

2.7%

-0.7%

-10.5%


You may also like the below Video Courses